STATUTORY RULES
1972 No.
________
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1971.*
WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1971 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1971, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1971.
Dated this ninth day of March, 1972.
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
_____
Amendments of the National Health (Pharmaceutical Benefits) Regulations
Commencement.
1. These Regulations shall come into operation on the first day of April, 1972.
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:
FIRST SCHEDULE Regulation 10.
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits
1. Acetomenaphthone 2. Acetomenaphthone Tablets 3. Acetrizoic Acid 4. Alcohol Dehydrated 5. Alcohol (95%) 6. Allopurinol 7. Aloes | 8. Almond Oil 9. Aluminium Hydroxide Tablets 10. Amethocaine Hydrochloride 11. Amitriptyline Injection 12. Amodiaquine Tablets 13. Amphetamine Sulphate 14. Amphetamine Sulphate Tablets |
_________________________________________________________________________________________________
* Notified in the Commonwealth Gazette on 1972.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; and 1971, Nos. 44, 101, 136 and 154.
11464/72—Price 30c 9/3.3.1972
15. Amylobarbitone Sodium Tablets 16. Antazoline Hydrochloride 17. Antazoline Tablets 18. Antimony Sodium Tartrate 19. Antimony Sodium Tartrate Injection 20. Apomorphine Hydrochloride 21. Apomorphine Injection 22. Arachis Oil 23. Aspirin Phenacetin and Codeine Tablets 24. Aspirin Phenacetin and Codeine Tablets Soluble 25. Azathioprine 26. Bacillus Calmette-Guérin Vaccine 27. Barium Sulphate 28. Beclomethasone Dipropionate 29. Belladonna Herb 30. Belladonna Herb, Powdered 31. Bemegride 32. Bendrofluazide 33. Bemgride Injection 34. Benzhexol Hydrochloride 35. Benzyl Alcohol 36. Betamethasone Sodium Phosphate Tablets 37. Bethanidine Sulphate 38. Bisacodyl 39. Bisacodyl Suppositories 40. Bisacodyl Tablets 41. Botulinum Antitoxin 42. Bupivacaine Hydrochloride 43. Busulphan 44. Butobarbitone 45. Butylated Hydroxyanisole 46. Butylated Hydroxytoluene 47. Caffeine Hydrate 48. Calciferol Solution 49. Calcium Cyclamate 50. Camphor 51. Caramiphen Hydrochloride 52. Caramiphen Tablets 53. Caraway 54. Carbimazole 55. Carbon Dioxide 56. Carbromal 57. Carbromal Tablets 58. Cardamom Fruit 59. Cascara 60. Catgut, Sterilised, Surgical 61. Cellulose, Oxidised 62. Cetylpyridinium Chloride 63. Chlorambucil 64. Chlordiazepoxide Capsules 65. Chlordiazepoxide Hydrochloride 66. Chlorhexidine Gluconate Solution 67. Chlorhexidine Hydrochloride 68. Chloroform 69. Chlormadinone Acetate 70. Chloroquine Phosphate 71. Chloroquine Phosphate Injection 72. Chloroquine Sulphate 73. Chlorothiazide 74. Chlorotrianisene 75. Chlorotrianisene Capsules 76. Chlorphenesin 77. Chlorproguanil Hydrochloride 78. Chlorproguanil Tablets 79. Chlorpropamide 80. Chlortetracycline Hydrochloride
| 81. Chlorthalidone 82. Cholera Vaccine Mixed 83. Choline Theophyllinate Tablets 84. Cinchocaine Hydrochloride 85. Cinnamon 86. Clofibrate 87. Cochineal 88. Colchicine 89. Colchicum Corm 90. Colchicum Liquid Extract 91. Colchicum Tincture 92. Colistin Tablets 93. Colophony 94. Concentrated Peppermint Water 95. Coriander 96. Coriander Oil 97. Corticotrophin 98. Corticotrophin Injection 99. Corticotrophin Gelatin Injection 100. Corticotrophin Zinc Hydroxide Injection 101. Cortisone Acetate 102. Cottonseed Oil 103. Cresol 104. Cresol and Soap Solution 105. Crotamiton 106. Cyanocobalamin 107. Cyanocobalamin (57Co) 108. Cyanocobalamin (58Co) 109. Cyclamic Acid 110. Cyclizine Tablets 111. Cyclobarbitone Calcium 112. Cyclomethycaine Sulphate 113. Cyclopenthiazide 114. Cyclopentolate Hydrochloride 115. Cyclopropane 116. Cycloserine 117. Cycloserine Tablets 118. Dapsone 119. Dequalinium Acetate 120. Dequalinium Chloride 121. Desipramine Hydrochloride 122. Dexamphetamine Sulphate 123. Dexamphetamine Tablets 124. Dextran 110 Injection 125. Dextromethorphan Hydrobromide 126. Dextromethorphan Tablets 127. Dextropropoxyphene Capsules 128. Dextropropoxyphene Hydrochloride 129. Dextropropoxyphene Napsylate 130. Dextrose Monohydrate 131. Diamorphine Hydrochloride 132. Diamorphine Injection 133. Diazepam Capsules 134. Dibromopropamidine Isethionate 135. Dichloralphenazone 136. Dichlorophen 137. Dichlorphenamide 138. Diethylcarbamazine Citrate 139. Diethylcarbamazine Tablets 140. Digitalis Leaf 141. Digitalis Prepared 142. Digitoxin 143. Digitoxin Tablets 144. Dihydrocodeine Injection 145. Dihydrocodeine Tablets 146. Diloxanide Furoate 147. Dilute Alcohols
|
First Schedule—continued
148. Dimenhydrinate 149. Dimenhydrinate Injection 150. Dimenhydrinate Tablets 151. Dimercaprol 152. Dimethisterone 153. Dimethisterone Tablets 154. Diodone Injection 155. Diphtheria and Pertussis Vaccine 156. Diphtheria, Tetanus and Poliomyelitis Vaccine 157. Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine 158. Dipipanone Hydrochloride 159. Dipipanone Injection 160. Dodecyl Gallate 161. Domiphen Bromide 162. Dried Human Albumin 163. Dusting Powder Absorbable 164. Edrophonium Chloride 165. Edrophonium Injection 166. Eltor Vaccine 167. Emetine and Bismuth Iodide 168. Emetine Hydrochloride 169. Erythromycin 170. Ethacrynic Acid 171. Ethchlorvynol 172. Ether Anaesthetic 173. Ethinyloestradiol 174. Ethionamide 175. Ethisterone 176. Ethopropazine Hydrochloride 177. Ethotoin 178. Ethyl Chloride 179. Ethyl Oleate 180. Ethylenediamine Hydrate 181. Eucalyptus Oil 182. Ethynodiol Diacetate 183. Eugenol 184. Ferric Citrate (50Fe) Injection 185. Ferrous Fumarate 186. Ferrous Succinate Tablets 187. Fludrocortisone Acetate 188. Fluoxymesterone 189. Gallamine Triethiodide 190. Gallamine Injection 191. Gamma Benzene Hexachloride 192. Gelatin Sponge, Absorbable 193. Gentian 194. Gentian Tincture, Compound 195. Ginger 196. Gold (108Au) Injection 197. Halothane 198. Helium 199. Heparin 200. Hexachlorophane 201. Hexylresorcinol 202. Histamine Acid Phosphate 203. Histamine Acid Phosphate Injection 204. Human Albumin 205. Human Blood, Whole 206. Human Red Blood Corpuscles, Concentrated 207. Human Fibrin Foam 208. Human Fibrinogen 209. Human Normal Gamma Globulin Injection 210. Human Plasma, Dried 211. Human Plasma Protein Fraction | 212. Human Plasma Protein Fraction, Dried 213. Human Serum, Dried 214. Human Thrombin 215. Hydrochlorothiazide 216. Hydrocortisone Hydrogen Succinate 217. Hydroflumethiazide 218. Hydrogen Peroxide Solution, Strong 219. Hydroxocobalamin 220. Hydroxychloroquine Sulphate 221. Hyoscine Injection 222. Hyoscine Eye Ointment 223. Hyoscine Tablets 224. Hyoscyamus 225. Hyoscyamus Dry Extract 226. Indigo Carmine 227. Influenza Vaccine 228. Industrial Methylated Spirit 229. Inulin 230. Inulin Injection 231. Iodinated (131I) Human Serum Albumin Injection 232. Iodipamide Meglumine Injection 233. Iodised Oil Fluid Injection 234. Iopanoic Acid 235. Iopanoic Acid Tablets 236. Iophendylate Injection 237. Iothalamic Acid 238. Ipecacuanha, Prepared 239. Isocarboxazid 240. Isocarboxazid Tablets 241. Isoniazid 242. Isopropyl Alcohol 243. Kaolin, Heavy 244. Laevulose 245. Lemon Peel, Dried 246. Levallorphan Injection 247. Levorphanol Injection 248. Levorphanol Tablets 249. Levorphanol Tartrate 250. Lignocaine and Adrenaline Injection 251. Liothyronine Sodium 252. Liquorice 253. Lithium Carbonate 254. Lucanthone Hydrochloride 255. Lucanthone Tablets 256. Lynoestrenol 257. Magnesium Stearate 258. Maize Oil 259. Male Fern 260. Male Fern Extract 261. Maleic Acid 262. Measles Vaccine (Inactivated) 263. Measles Vaccine (Live Attenuated) 264. Mecamylamine Hydrochloride 265. Mefenamic Acid 266. Mefenamic Acid Capsules 267. Megestrol Acetate 268. Meglumine Iothalamate Injection 269. Melarsoprol 270. Melarsoprol Injection 271. Mepacrine Hydrochloride 272. Mephentermine Sulphate 273. Meprobamate 274. Meprobamate Tablets 275. Mepyramine Injection 276. Mepyramine Maleate 277. Mepyramine Tablets 278. Mercaptopurine |
First Schedule—continued
279. Mersalyl Acid 280. Mestranol 281. Metaraminol Tartrate 282. Methadone Hydrochloride 283. Methandienone 284. Methicillin Sodium 285. Methohexitone Injection 286. Methoin 287. Methoserpidine 288. Methoserpidine Tablets 289. Methoxyflurane 290. Methyl Hydroxybenzoate 291. Methylamphetamine Hydrochloride 292. Methylamphetamine Injection 293. Methylamphetamine Tablets 294. Methyldopa 295. Methylergometrine Maleate 296. Methylprednisolone Tablets 297. Methylthiouracil 298. Methylthiouracil Tablets 299. Methyprylone 300. Methyprylone Tablets 301. Metronidazole 302. Morphine Sulphate Tablets 303. Nalorphine Hydrobromide 304. Nandrolone Decanoate 305. Nandrolone Phenylpropionate 306. Naphazoline Hydrochloride 307. Nealbarbitone 308. Nealbarbitone Tablets 309. Neostigmine Bromide 310. Nialamide 311. Nialamide Tablets 312. Niclosamide 313. Nicotinic Acid 314. Nicoumalone 315. Nikethamide 316. Nikethamide Injection 317. Nitrous Oxide 318. Norethandrolone 319. Norethandrolone Tablets 320. Norethisterone 321. Norethynodrel 322. Noscapine 323. Novobiocin Calcium 324. Novobiocin Sodium 325. Novobiocin Tablets 326. Nux Vomica 327. Octyl Gallate 328. Oestradiol Benzoate 329. Olive Oil 330. Opium 331. Opium, Powdered 332. Orange Peel, Dried Bitter 333. Orphenadrine Hydrochloride 334. Oxygen 335. Oxyphenbutazone 336. Oxyphenbutazone Tablets 337. Oxyphencyclimine Hydrochloride 338. Oxytetracycline Tablets 339. Oxytocin Tablets 340. Paramethadione 341. Paramomycin Capsules 342. Paramomycin Sulphate 343. Pempidine Tartarate 344. Penicillamine 345. Penicillamine Hydrochloride 346. Pentamidine Isethionate | 347. Pentamidine Injection 348. Pentolinium Tartrate Tablets 349. Peppermint Oil 350. Percutaneous Bacillus Calmette-Guérin Vaccine 351. Perphenazine 352. Perphenazine Tablets 353. Pethidine Tablets 354. Phenacetin 355. Phenazocine Hydrobromide 356. Phenazocine Injection 357. Phenazocine Tablets 358. Phenelzine Sulphate 359. Phenelzine Tablets 360. Phenindamine Tartrate 361. Phenindione 362. Phenmetrazine Hydrochloride 363. Phenmetrazine Tablets 364. Phenolphthalein Tablets 365. Phenolsulphonphthalein 366. Phenoxybenzamine Capsules 367. Phenoxybenzamine Hydrochloride 368. Phenoxymethylpenicillin 369. Phenoxymethylpenicillin Potassium 370. Phentolamine Mesylate 371. Phentolamine Injection 372. Phosphoric Acid 373. Phytomenadione Capsules 374. Phytomenadione Tablets 375. Piperazine Citrate 376. Piperazine Phosphate Tablets 377. Poldine Methylsulphate 378. Poldine Tablets 379. Poliomyelitis Vaccine (Inactivated) 380. Poliomyelitis Vaccine (Oral) 381. Potassium Bromide 382. Potassium Chloride Injection 383. Potassium Hydroxide 384. Potassium Nitrate 385. Prednisolone Pivalate Injection 386. Prednisone Acetate 387. Primaquine Phosphate 388. Probenecid 389. Procainamide Tablets 390. Procaine and Adrenaline Injection 391. Prochlorperazine Maleate 392. Prochlorperazine Mesylate 393. Procyclidine Hydrochloride 394. Progesterone 395. Proguanil Hydrochloride 396. Promazine Hydrochloride 397. Promazine Injection 398. Promazine Tablets 399. Promethazine Theoclate 400. Propranolol Hydrochloride 401. Propyl Gallate 402. Propyliodone 403. Propyliodone Injection 404. Propyliodone Oily Injection 405. Propylthiouracil 406. Pyrazinamide 407. Pyridostigmine Bromide 408. Pyrimethamine 409. Pyroxylin 410. Quillaia 411. Quinine Dihydrochloride 412. Quinine Dihydrochloride Injection 413. Rabies Antiserum |
First Schedule—continued
414. Rabies Vaccine 415. Sesame Oil 416. Silver Nitrate, Toughened 417. Soda Lime 418. Sodium Acetate 419. Sodium Acetrizoate Injection 420. Sodium Antimonylgluconate 421. Sodium Antimonylgluconate Injection 422. Sodium Aurothiomalate 423. Sodium Bicarbonate Compound Tablets 424. Sodium Bromide 425. Sodium Calciumedetate 426. Sodium Chromate (51Cr) Solution 427. Sodium Citrate Tablets 428. Sodium Cyclamate 429. Sodium Diatrizoate 430. Sodium Diatrizoate Injection 431. Sodium Fluoride 432. Sodium Fusidate Capsules 433. Sodium Hydroxide 434. Sodium Iodide (131I) Injection 435. Sodium Iodide (125I) Solution 436. Sodium Iodide (131I) Solution 437. Sodium Iodohippurate (131I) Injection 438. Sodium Iothalamate Injection 439. Sodium Lauryl Sulphate 440. Sodium Phosphate (32P) Injection 441. Sodium Stibogluconate 442. Sodium Stibogluconate Injection 443. Solapsone 444. Solapsone Tablets 445. Spironolactone 446. Staphylococcus Antitoxin 447. Stibophen 448. Stibophen Injection 449. Stramonium 450. Sulphadiazine Sodium 451. Sulphadimethoxine 452. Sulphadimidine Injection 453. Sulphadimidine Sodium 454. Sulphamethizole 455. Sulphamethoxydiazine 456. Sulphamethoxypridazine 457. Sulphapyridine 458. Sulphinpyrazone 459. Sulphobromophthalein Sodium 460. Sulphomyxin Injection 461. Sulphomyxin Sodium 462. Sulthiame 463. Suramin 464. Suramin Injection 465. Suxamethonium Chloride | 466. Suxamethonium Bromide 467. Suxamethonium Chloride Injection 468. Testosterone 469. Testosterone Phenylpropionate Injection 470. Tetanus and Pertussis Vaccine 471. Tetanus Vaccine (Alum Precipitated) 472. Tetanus Vaccine (Simple Solution) 473. Tetrachloroethylene 474. Tetrachloroethylene Capsules 475. Tetracycline Tablets 476. Thiomersal 477. Thiopentone Sodium 478. Thiopentone Injection 479. Thioridazine Hydrochloride 480. Thyroid 481. Thyroxine Sodium 482. Tolnaftate 483. Tolazoline Hydrochloride 484. Tolazoline Tablets 485. Tolbutamide 486. Tolu Balsam 487. Tranylcypromine Sulphate 488. Tranylcypromine Tablets 489. Triamterene Capsules 490. Trichloroethylene 491. Tricyclamol Chloride 492. Tricyclamol Tablets 493. Tryparsamide 494. Tryparsamide Injection 495. Tuberculin, Old 496. Tuberculin Purified Protein Derivative 497. Tubocurarine Chloride 498. Tubocurarine Injection 499. Turpentine Oil 500. Typhoid-Paratyphoid A and B 501. Typhoid-Paratyphoid A and B and Cholera Vaccine 502. Typhoid-Paratyphoid A and B and Tetanus Vaccine 503. Typhoid-Paratyphoid A, B and C Vaccine 504. Undecenoic Acid 505. Urea 506. Urea Injection 507. Vancomycin Hydrochloride 508. Vancomycin Injection 509. Vinyl Ether 510. Vitamin A Ester Concentrate 511. Yellow Fever Vaccine 512. Zinc Undecenoate 513. Zinc Undecenoate Ointment |
________________
SECOND SCHEDULE Regulation 10 (3.).
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
1 | Acepifylline ....................... | — |
2 | Acetylsulphafurazole................. | — |
3 | Acetylcysteine...................... | — |
4 | Acrylic Resin...................... | — |
5 | Adrenaline Hydrochloride.............. | — |
6 | Albumaid XP...................... | — |
7 | Aluminium Sodium Silicate............. | — |
8 | Amino Acids....................... | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
9 | Aminogran........................ | — |
10 | Amphotericin B..................... | Tetracycline, B.P.C. with buffering agent and Amphotericin B |
11 | Ampicillin........................ | — |
12 | Ampicillin Trihydrate................. | — |
13 | Antazoline Sulphate.................. | Naphazoline Nitrate with Antazoline Sulphate |
14 | Ascorbic Acid...................... | Vitamin A with Thiamine Hydrochloride, Riboflavine Nicotinamide, Vitamin D and Ascorbic Acid |
|
| Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary |
|
| Ferrous Sulphate mixture Prescribers List |
|
| Ferrous Sulphate mixture Prescribers List Children’s Section |
15 | Attapulgite........................ | Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite |
16 | Bacitracin......................... | Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin |
17 | Bacitracin Zinc..................... | Neomycin Undecenoate with Bacitracin Zinc |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc |
18 | Belladonna Herb, Prepared............. | Phenobarbitone with Belladonna Herb, Prepared |
19 | Belladonna, Dry Extract............... | Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna |
20 | Betamethasone..................... | Betamethasone Acetate with Betamethasone |
21 | Betamethasone Acetate................ | Betamethasone with Betamethasone Acetate |
22 | Betamethasone Sodium Phosphate........ | — |
23 | Betamethasone Phosphate.............. | — |
24 | Betamethasone Valerate............... | Clioquinol with Betamethasone Valerate |
25 | Brompheniramine Maleate.............. | — |
26 | Calciferol......................... | — |
27 | Calcium Di-Oxytetracycline............. | — |
28
| Capsicum Oleoresin..................
| Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954 and Capsicum Oleoresin |
29 | Carbachol......................... | Hypromellose 4500 with Carbachol |
30 | Carbinoxamine Maleate............... | — |
31
| Cascara Dry Extract..................
| Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954 and Cascara Dry Extract |
32 | Ceratonia, B.P.C. 1949................ | — |
33 | Chloramine, B.P.C................... | — |
34 | Chloramphenicol.................... | Polymyxin B Sulphate with Chloramphenicol Hydrocortisone Acetate with Chloramphenicol |
|
| |
35 | Chloramphenicol Palmitate, B.P.C......... | — |
36 | Chloramphenicol Stearate.............. | — |
37 | Chlorhexidine Gluconate............... | — |
38 | Chlorpheniramine Maleate.............. | — |
39 | Chlorpromazine Hydrochloride........... | — |
40 | Choline Theophyllinate................ | Guaiphenesin with Choline Theophyllinate |
41 | Clemizole Tannate................... | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
42 | Clioquinol........................ | Betamethasone Valerate with Clioquinol |
|
| Flumethasone Pivalate with Clioquinol |
43 | Colistin Sulphate.................... | Neomycin Sulphate with Colistin Sulphate |
44 | Cortisone Acetate.................... | — |
45 | Cyclizine Hydrochloride............... | Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride |
46 | Cymogran........................ | — |
47 | Cyproheptadine Hydrochloride | — |
48 | Danthron......................... | Dioctyl Sodium Sulphosuccinate, B.P.C. with Danthron |
49 | Demecarium Bromide................. | — |
50 | Demethylchlortetracycline Hydrochloride | Nystatin with Demethylchlortetracycline Hydrochloride |
51 | Dexamethasone..................... | Framycetin Sulphate with Gramicidin and Dexamethasone |
52 | Dexamethasone Metasulphobenzoate | Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate |
53 | Dexchlorpheniramine Maleate........... | — |
54 | Dextrans......................... | Dextrose with Dextrans |
|
| Sodium Chloride with Dextrans |
55 | Dextrose Polymer................... | — |
56 | Diazepam......................... | — |
57 | Dichloralphenazone.................. | — |
58 | Dicyclomine Hydrochloride............. | Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride |
59 | Dienoestrol........................ | — |
60 | Diethanolamine Fusidate............... | — |
61 | Digoxin.......................... | — |
62 | Dihydrocodeine Tartrate............... | — |
63 | Dihydrostreptomycin Sulphate, B.P. 1958 | Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
|
| Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958 |
64 | Dihydrotachysterol................... | — |
65 | Dimethicone, B.P.C................... | — |
66 | Dioctyl Sodium Sulphosuccinate, B.P.C..... | Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C. |
67 | Diphenhydramine Hydrochloride | Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride |
68 | Diphenylpyraline Hydrochloride | — |
69 | Diphtheria Vaccine.................. | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
|
| Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
70 | Doxycycline Hyclate................. | — |
71 | Doxylamine Succinate................ | Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate |
72 | Ecothiopate Iodide................... | — |
73 | Ergometrine Maleate................. | Oxytocin with Ergometrine Maleate |
74 | Ergotamine Tartrate.................. | Caffeine with Ergotamine Tartrate |
|
| Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate |
|
| Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate |
75 | Erythromycin Estolate................ | — |
76 | Erythromycin Stearate................ | — |
77 | Ethosuximide...................... | — |
78 | Ferric Hydroxide.................... | — |
79 | Ferrous Aminoacetosulphate............ | — |
80 | Ferrous Succinate.................... | — |
81 | Flumethasone Pivalate................ | Clioquinol with Flumethasone Pivalate |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
82 | Fluphenazine Hydrochloride | — |
83 | Framycetin Sulphate.................. | Light Kaolin with Framycetin Sulphate |
|
| Dexamethasone with Framycetin Sulphate and Gramicidin |
|
| Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate |
84 | Galactomin, Formula No. 17 | — |
85 | Galactomin, Formula No. 19 | — |
86 | Glucose Indicator, Blood............... | — |
87 | Glucose Indicator, Urine............... | — |
88 | Goat’s Milk, Dehydrated............... | — |
89 | Goat’s Milk....................... | — |
90 | Gramicidin........................ | Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone and Gramicidin |
|
| Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin |
|
| Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin |
91 | Guaiphenesin, B.P.C.................. | Theophylline with Guaiphenesin, B.P.C. |
92 | Hydrocortisone..................... | Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone |
|
| Neomycin Sulphate with Hydrocortisone |
|
| Natamycin with Neomycin Sulphate and Hydrocortisone |
93 | Hydrocortisone Acetate................ | Neomycin Sulphate with Hydrocortisone Acetate |
|
| Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate |
|
| Oxytetracycline Hydrochloride and Hydrocortisone Acetate |
|
| Chloramphenicol with Hydrocortisone Acetate |
94 | Hyoscine Hydrobromide............... | Hypromellose 4500 with Hyoscine Hydrobromide |
|
| Papaveretum with Hyoscine Hydrobromide |
|
| Pethidine Hydrochloride with Hyoscine Hydrobromide |
|
| Morphine Sulphate with Hyoscine Hydrobromide |
95 | Idoxuridine........................ | — |
96 | Ipecacuanha....................... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959 and Ipecacuanha |
97 | Isoniazid......................... | Sodium Aminosalicylate with Isoniazid |
98 | Isoprenaline Hydrochloride............. | — |
99 | Kanamycin Sulphate, B.P.C. | — |
100 | Lauryl Dimethylbenzyl Ammonium Chloride | ‘TERIC’ N8 with Lauryl Dimethylbenzyl Ammonium Chloride |
101 | Levallorphan Tartrate................. | Pethidine Hydrochloride with Levallorphan Tartrate |
102 | Lignocaine Hydrochloride.............. | Polymyxin B Sulphate with Propylene Glycol and Lignocaine Hydrochloride |
103 | Lincomycin Hydrochloride............. | — |
104 | Locasol.......................... | — |
105 | Lofenalac......................... | — |
106 | Lypressin......................... | — |
107 | Magnesium Aluminium Hydroxide | — |
108 | Magnesium Chloride................. | Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride |
|
| Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride |
109 | Magnesium Hydroxide, B.P.C............ | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
109—cont. |
| Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C. |
|
| Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C. |
110 | Mebhydrolin Napadisylate, B.P.C. | — |
111 | Meclastine Hydrogen Fumarate | — |
112 | Meclozine Hydrochloride............... | Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride |
113 | Meglumine........................ | Theophylline with Meglumine |
114 | Methacycline....................... | — |
115 | Methdilazine Hydrochloride | — |
116 | Methenamine Mandelate............... | — |
117 | Minafen.......................... | — |
118 | Morphine Tartrate................... | Morphine Tartrate with Tacrine |
119 | Nalidixic Acid, B.P.C.................. | — |
120 | Naphazoline Nitrate.................. | Naphazoline Nitrate with Antazoline Sulphate |
121 | Natamycin........................ | Neomycin Sulphate with Hydrocortisone and Natamycin |
122 | Neomycin Sulphate.................. | Hydrocortisone Acetate with Neomycin Sulphate |
|
| Hydrocortisone with Neomycin Sulphate |
|
| Colistin Sulphate with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Kaolin with Neomycin Sulphate |
|
| Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate |
|
| Prednisolone Sodium Phosphate with Neomycin Sulphate |
|
| Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate |
|
| Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate |
|
| Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate |
|
| Natamycin with Hydrocortisone and Neomycin Sulphate |
123 | Neomycin Undecenoate................ | Bacitracin Zinc with Neomycin Undecenoate |
124 | Neostigmine Methylsulphate............ | — |
125 | Nicotinamide....................... | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
126 | Nitrofurantoin...................... | — |
127 | Noradrenaline Acid Tartrate............. | — |
128 | Nortriptyline Hydrochloride............. | — |
129 | Nystatin.......................... | Tetracycline, B.P.C. with a buffering agent and Nystatin |
|
| Demethylchlortetracycline with Nystatin |
|
| Tetracycline Hydrochloride with Nystatin |
|
| Gramicidin with Neomycin Sulphate |
|
| Triamcinolone Acetonide and Nystatin |
|
| Oxytetracycline Dihydrate with Nystatin |
130 | Nutramigen........................ | — |
131 | Octatropine Methylbromide............. | — |
132 | Orciprenaline Sulphate................ | — |
133 | Oxytetracycline Dihydrate.............. | Nystatin with Oxytetracycline Dihydrate |
134 | Oxytetracycline Hydrochloride........... | Polymyxin B Sulphate with Oxytetracycline Hydrochloride |
|
| Hydrocortisone Acetate with Oxytetracycline Hydrochloride |
135 | Oxethazaine....................... | Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine |
136 | Oxytocin......................... | Ergometrine Maleate with Oxytocin |
137 | Pancreatin......................... | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
138 | Pancreatin Enzyme, 4 times U.S.N.F.XII strength |
— |
139 | Papaveretum, B.P.C................... | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
140 | Penicillin, Benethamine, B.P.C. | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
141 | Penicillin, Benzathine................. | Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin |
142 | Penicillin, Benzyl.................... | Procaine Penicillin with Benzyl Penicillin |
143
| Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt) | —
|
144 | Penicillin, Potassium................. | Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin |
145 | Penicillin, Procaine.................. | Benethamine Penicillin, B.P.C. with Sodium Penicillin Procaine Penicillin |
|
| Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin |
|
| Benzyl Penicillin with Procaine Penicillin |
146 | Penicillin, Sodium................... | Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin |
147 | Pentobarbitone..................... | Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone |
148 | Pericyazine........................ | — |
149 | Pertussis Vaccine.................... | Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine |
150 | Pethidine Hydrochloride............... | Levallorphan Tartrate with Pethidine Hydrochloride |
|
| Hyoscine Hydrobromide with Pethidine Hydrochloride |
151 | Phenethicillin Potassium............... | — |
152 | Pheniramine Maleate................. | — |
153 | Phenytoin, B.P.C..................... | — |
154 | Pholcodine........................ | — |
155 | Pipenzolate Methobromide............. | — |
156 | Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
157 | PK AID I......................... | — |
158 | PK AID II........................ | — |
159 | Plasma Substitute (Polypeptide) | — |
160 | Polyisobutylene..................... | — |
161 | Polymyxin B Sulphate................ | Chloramphenicol with Polymyxin B Sulphate |
|
| Oxytetracycline Hydrochloride with Polymyxin B Sulphate |
|
| Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate |
|
| Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin |
|
| Propylene Glycol with Acetic Acid and Polymyxin B Sulphate |
|
| Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate |
|
| Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate |
|
| Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate |
162 | Polyvinyl Alcohol................... | Pilocarpine Nitrate and Polyvinyl Alcohol |
163 | Prednisolone....................... | — |
164 | Prednisolone Acetate................. | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. |
165 | Methylprednisolone.................. | — |
166 | Prednisolone Sodium Hemisulphate | Sulphaethidole with Prednisolone Sodium Hemisulphate |
167 | Prednisolone Sodium Phosphate | Neomycin Sulphate with Prednisolone Sodium Phosphate |
168 | Prednisolone Pivalate................. | — |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
169 | Primidone......................... | — |
170 | Promethazine Hydrochloride............ | — |
171 | Pseudoephedrine Hydrochloride.......... | — |
172 | Pyrantel Embonate................... | — |
173 | Pyridoxine Hydrochloride.............. | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride |
174 | Prosobee.......................... | — |
175 | Riboflavine........................ | Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine |
176 | Salbutamol........................ | — |
177 | Senna Fruit........................ | — |
178 | Silver Nitrate, Toughened.............. | — |
179 | Similac Isomil...................... | — |
180 | Sobee............................ | — |
181 | Sodium Acid Citrate.................. | — |
182 | Sodium Lactate..................... | Potassium Chloride with Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate |
|
| Potassium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Dextrose and Sodium Lactate |
|
| Sodium Chloride with Sodium Lactate |
183 | Sodium Potassium Tartrate, B.P.C | Compound Effervescent Powder, B.P.C. |
184 | Sodium Tauroglycocholate, B.P.C. 1954 | Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954 |
185 | Sorbitol.......................... | Amino Acids with Sorbitol |
|
| Amino Acids with Sorbitol and Alcohol |
186 | Soyalac.......................... | — |
187 | Strychnine, B.P.C. 1959............... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959 |
188 | Sulphaethidole..................... | Prednisolone Sodium Hemisulphate with Sulphaethidole |
189 | Sulphafurazole..................... | — |
190 | Sulphamethizole.................... | — |
191 | Sulphamethoxazole.................. | Trimethoprim with Sulphamethoxazole |
192 | Sulphaphenazole, B.P.C................ | — |
193 | Surgical Cement.................... | — |
194 | Surgical Cement Solvent............... | — |
195 | Tacrine | Morphine Sulphate with Tacrine |
|
| Morphine Tartrate with Tacrine |
196 | ‘TERIC’ N8....................... | Lauryl Dimethylbenzyl Ammonium Chloride with ‘TERIC’ N8 |
197 | Testosterone Decanoate................ | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
198 | Testosterone Isocaproate............... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
199 | Testosterone Phenylpropionate........... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
200 | Testosterone Propionate............... | Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate |
|
| Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
201 | Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) | Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed) |
Second Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Allowable Compounds (if any) |
202 | Tetracycline, B.P.C................... | Tetracycline, B.P.C. with a buffering agent |
|
| Tetracycline, B.P.C. with a buffering agent and Amphotericin B |
|
| Tetracycline, B.P.C. with a buffering agent and Nystatin |
203 | Tetracycline Hydrochloride............. | Tetracycline Hydrochloride with Nystatin |
|
| Procaine Hydrochloride with Tetracycline Hydrochloride |
204 | Thiamine Hydrochloride............... | Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride |
205 | Thioridazine....................... | — |
206 | Thiotepa.......................... | — |
207 | Thonzonium Bromide................. | Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide |
208 | Thonzylamine Hydrochloride | Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride |
209 | Tiemonium Iodide................... | — |
210 | Tragacanth, Indian (Gum Karaya) | — |
211 | Triamcinolone Acetonide.............. | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
212 | Triclofos Sodium.................... | — |
213 | Trifluoperazine Hydrochloride | — |
214 | Triglyde.......................... | — |
215 | Trimeprazine Tartrate, B.P.C. | — |
216 | Trimethoprim...................... | Trimethoprim with Sulphamethoxazole |
217 | Triprolidine Hydrochloride............. | — |
218 | Vinyl Acetate...................... | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine |
219 | Vinyl Pyrrolidone................... | Vinyl Acetate and Vinyl Pyrrolidone with Benzocaine |
220 | Viprynium Embonate................. | — |
221 | Vitamin A........................ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A |
222 | Vitamin D........................ | Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D |
_________________
THIRD SCHEDULE Regulation 11.
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
1. Acepifylline 2. Acetazolamide Sodium 3. Acetohexamide 4. Acetylcholine Chloride 5. Acetylcysteine 6. Acetyl Sulphafurazole 7. Acidified Golden Syrup, A.P.F. 1955 8. Acriflavine, B.P.C. 1963 9. Acrylic Resin 10. Adenaline Hydrochloride 11. Adrenaline Mucate 12. Albumaid XP 13. Aldosterone 14. Aloin, B.P.C. 15. Almond Oil Volatile Bitter, B.P.C. 1959 16. Aloxiprin 17. Alprenolol Hydrochloride 18. Aluminium Acetate Solution, B.P.C. 19. Aluminium Hydroxide Mixture, A.P.F. | 20. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex 21. Aluminium Sodium Silicate 22. Amantadine Hydrochloride 23. Amaranth Solution, A.P.F. 24. Amaranth Solution, Compound, A.P.F. 25. Amaranth Solution, B.P.C. 26. Ambenonium Chloride 27. Amino Acids 28. Aminocaproic Acid 29. Aminogran 30. Aminosalicylic Acid 31. Amitriptyline Embonate 32. Ammonia Aromatic Spirit, B.P.C. 33. Ammonia Solution, strong, B.P.C. 34. Ammonium Acetate Solution, strong, B.P.C. 35. Ammonium Bicarbonate, B.P.C. 36. Amphotericin B |
Third Schedule—continued
37. Angiotensin Amide 38. Antazoline Mesylate, B.P.C. 39. Antazoline Sulphate 40. Anti-Haemophilic Factor of Animal Origin 41. Attapulgite 42. Bacitracin Zinc 43. Belladonna Suppository, B.P. 1948 44. Benzalkonium Chloride 45. Benzoin Compound Tincture, B.P.C. 46. Bephenium Hydroxynaphthoate, B.P.C. 47. Betahistine Hydrochloride 48. Betamethasone Acetate 49. Betamethasone Phosphate 50. Black Snake Antivenene 51. Biperiden Hydrochloride 52. Bismuth Subgallate, B.P.C. 53. Brompheniramine Maleate 54. Brown Snake Antivenene 55. Buchu Concentrated Infusion, B.P.C. 1954 56. Cade Oil, B.P.C. 57. Caffeine and Sodium Benzoate, B.P.C. 1954 58. Caffeine Citrate, B.P.C. 1959 59. Calcium Di-Oxytetracycline 60. Calcium Gluconogalactogluconate 61. Capreomycin Sulphate 62. Capsicum Ointment, B.P.C. 63. Capsicum Oleoresin 64. Carbamazepine 65. Carbenoxolone Sodium 66. Carbinoxamine Maleate 67. Cardamon Aromatic Tincture, B.P.C. 68. Catechu Tincture, B.P.C. 69. Cephalexin Monohydrate 70. Cephalothin Sodium 71. Ceratonia, B.P.C. 1949 72. Cetomacrogol Emulsifying Wax. B.P.C. 73. Charcoal 74. Chloramine, B.P.C. 75. Chloramphenicol Palmitate, B.P.C. 76. Chloramphenicol Stearate 77. Chloramphenicol Succinate 78. Chlorhexidine Acetate 79. Chlorhexidine Gluconate 80. Cholestyramine 81. Clemizole Hydrochloride 82. Clemizole Tannate 83. Clopamide 84. Clorexolone 85. Coal Tar, B.P.C. 86. Coal Tar Solution Strong, B.P.C. 87. Cochineal Tincture, B.P. 1948 88. Coconut Oil, B.P.C. 1949 89. Colophony Ointment, B.P.C. 1959 90. Copper Sulphate, B.P.C. 91. Creosote, B.P.C. 1959 92. Cyclothiazide 93. Cycrimine Hydrochloride 94. Cymogran 95. Cytosine Arabinoside Hydrochloride 96. Danthron 97. Death Adder Antivenene 98. Debrisoquine 99. Demecarium Bromide 100. Desferrioxamine Mesylate 101. Deslanoside | 102. Dexamethasone Metasulphobenzoate 103. Dexamethasone Sodium Phosphate 104. Dexchlorpheniramine Maleate 105. Dextrans 106. Dextriferron 107. Dextrose Polymer 108. Diazoxide 109. Dibenzepin Hydrochloride 110. Diethanolamine Fusidate, B.P.C. 111. Diethazine Hydrochloride, B.P. 1963 112. Dihydroergotamine Mesylate 113. Dihydroergotoxin Mesylate 114. Dihydrostreptomycin Sulphate, B.P. 1958 115. Dimethicone, B.P.C. 116. Dimethindene Maleate 117. Dioctyl Sodium Sulphosuccinate, B.P.C. 118. Diphenylpyraline Hydrochloride 119. Diphtheria Vaccine (Purified toxoid alumnium phosphate) diluted 120. Diphtheria and Tetanus Vaccine, Adult 121. Disodium Cromoglycate 122. Doxycycline Hyclate 123. Doxylamine Succinate 124. Droperidol 125. Ephedrine, B.P.C. 126. Epicillin 127. Erythrityl Tetranitrate 128. Erythromycin Ethyl Succinate 129. Erythromycin Glucoheptonate 130. Erythromycin Lactobionate 131. Ethanolamine Oleate 132. Ethoxzolamide 133 Ethylidene Dicoumarin 134. Ethylinoradrenaline Hydrochloride 135. Ethyloestrenol 136. Ferric Hydroxide 137. Ferrous Aminoacetosulphate 138. Ferrous Phosphate Compound, Syrup, B.P.C. 139. Flumethasone Pivalate 140. Fluorouracil Sodium 141. Fluphenazine Decanoate 142. Fluphenazine Enanthate 143. Flurandrenolone Acetonide 144. Framycetin Sulphate 145. Galactomin, Formula No. 17 146. Galactomin, Formula No. 19 147. Gall and Opium Ointment, B.P.C. 1963 148. Gelsemium Tincture, B.P.C. 149. Gentamicin Sulphate 150. Ginger Syrup, B.P.C. 151. Glibenclamide 152. Glucagon Hydrochloride 153. Glucose Indicator—Blood 154. Glucose Indicator—Urine 154. Glycerophosphate Compound Syrup, A.P.F. 156. Glycopyrronium Bromide 157. Glymidine 158. Goat’s Milk, Dehydrated 159. Goat’s Milk, Whole (Sterilised) 160. Gramicidin 161. Guaiphenesin, B.P.C. 162. Hamamelis Liquid Extract, B.P.C. 163. Hexocyclium Methylsulphate |
Third Schedule—continued
164. Haemodialysis Fluid—Concentrate 165. Hydrargaphen 166. Hydromorphone Hydrochloride 167. Hydroxyprogesterone 168. Hydroxyurea 169. Hyoscine Butylbromide 170. Hyoscine Methobromide 171. Hypophosphorous Acid, Dilute, B.P.C. 1963 172. Hypromellose 4500 173. Indomethacin 174. Influenza Vaccine—Sub Unit type (Desoxycholate Treated) 175. Injection of Amino Acids with Sorbitol and Alcohol 176. Injection of Casein Hydrolysate with Laevulose and Alcohol 177. Injection of Dextran with Dextrose 178. Injection of Potassium Chloride with Sodium Lactate and Dextrose 179. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose 180. Injection of Sodium Chloride with Sodium Lactate and Dextrose 181. Insect Allergan Extract—Honey Bee 182. Insect Allergan Extract—Jumper Ant 183. Insect Allergan Extract—Paper Wasp 184. Insulin Injection, specially purified 185. Insulin Isophane Injection, specially purified 186. Insulin Injection, Special P (Pig) 187. Invert Sugar 188. Iron Polymaltose Complex 189. Isoprenaline Hydrochloride 190. Isopropamide Iodide 191. Kanamycin Sulphate, B.P.C. 192. Lactulose 193. Lanatoside-C 194. Lauryl Dimethyl Benzyl Ammonium Chloride 195. Lavender Spike Oil, B.P.C. 196. Lead Subacetate Dilute Solution 197. Lead Subacetate Strong Solution, B.P.C. 198. Levodopa 199. Lemon Oil Terpencless, B.P.C. 200. Lemon Tincture, B.P. 1958 201. Leucovorin 202. Lincomycin Hydrochloride 203. Lipopancreatin 204. Lobelia Ethereal Tincture, B.P.C. 205. Locasol 206. Lofenalac 207. Lypressin 208. Magenta, B.P.C. 209. Magnesium-Aluminium Hydroxide 210. Magnesium Hydroxide, B.P.C. 211. Maphenide Acetate 212. Mebeverine Hydrochloride 213. Mebhydrolin Napadisylate, B.P.C. 214. Meclastine Hydrogen Fumarate 215. Medroxyprogesterone Acetate 216. Melphalan 217. Mepenzolate Bromide 218. Mercaptomerin Sodium 219. Mercuric Chloride, B.P.C. 220. Metaraminol Bitartrate 221. Methacycline | 222. Methaqualone Hydrochloride 223. Methdilazine Hydrochloride 224. Methenamine Mandelate 225. Methenolone Acetate 226. Methoxamine Hydrochloride, B.P.C. 227. Methsuximide 228. Methyclothiazide 229. Methylphenobarbitone, B.P.C. 1963 230. Methylprednisolone Acetate 231. Methylprednisolone Sodium Succinate 232. Methysergide Maleate 233. Metyrapone 234. Minafen 235. Minocycline Hydrochloride 236. Morphine Tartrate 237. Myrrh Tincture, B.P.C. 238. Nalidixic Acid, B.P.C. 239. Nandrolone Hexoxyphenyl Propionate 240. Natamycin 241. Neomycin Undecenoate 242. Nitrazepam 243. Nitromin 244. Nutramigen 245. Octatropine Methylbromide 246. Oestradiol Dipropionate, B.P.C. 1954 247. Oestrone, B.P.C. 1954 248. Oily Opthalmic Vehicle, A.P.F. 1955 249. Orange Syrup, B.P.C. 250. Orange Tincture, B.P.C. 251. Oxethazaine 252. Oxprenolol Hydrochloride 253. Oxycodone Pectinate 254. Oxymel, B.P.C. 255. Oxymel of Squill, B.P.C. 256. Oxymetholone 257. Oxyphenonium Bromide 258. Oxytetracycline 259. Oxytocin 260. Pancreatin Enzyme, U.S.N.F. XII 261. Papaveretum, B.P.C. 262. Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955 263. Paraben Ophthalmic Vehicle, A.P.F. 1955 264. Paraffin Liquid Light, B.P.C. 1963 265. Paramethasone Acetate 266. Pectin 267. Penicillinase 268. Penicillin Benethamine, B.P.C. 269. Pentaerythritol Tetranitrate, diluted, B.P.C. 270. Pentazocine Lactate 271. Penthienate Methobromide 272. Pentobarbitone 273. Pericyazine 274. Pericyazine Mesylate 275. Peritoneal Dialysis Solution with Dextrose 276. Phenformin Hydrochloride 277. Pheniramine Maleate 278. Pheniramine Para-Aminosalicylate 279. Phenol Ointment, B.P. 1948 280. Phenoxymethylpenicillin, Benzathine 281. Phenoxymethylpenicillin, Hydrabamine 282. Phensuximide, B.P.C. 283. Phenthimentonium 284. Phenytoin, B.P.C. 285. Phthalylsulphacetamide 286. Physostigmine, B.P.C. |
Third Schedule—continued
287. Pilocarpine Hydrochloride 288. Pipenzolate Methobromide 289. Pituitary Hormone, Follicle-stimulating, Human 290. Pituitary Hormone, Growth, Human 291. Pituitary (Posterior Lobe) Powdered, B.P.C. 292. Pizotifen Malate 293. PK AID I 294. PK AID II 295. Plasma Substitute (Polypeptide) 296. Polyisobutylene 297. Polyoestradiol Phosphate 298. Polyvinyl Alcohol 299. Potassium Chlorate, B.P.C. 300. Potassium Effervescent Tablets 301. Potassium Perchlorate 302. Practolol 303. Prednisolone Acetate 304. Prednisolone Sodium Succinate 305. Prednisolone Sodium Hemisulphate 306. Prednisolone Steaglate 307. Prednisolone Tertiary Butyl Acetate 308. Prindolol 309. Procarbazine Hydrochloride 310. Prochlorperazine 311. Proscillaridin 312. Prosobee 313. Protriptyline Hydrochloride 314. Pseudoephedrine Hydrochloride 315. Pumilio Pine Oil, B.P.C. 316. Pyrantel Embonate 317. Pyridine Aldoxime Methiodide 318. Quillaia Tincture, B.P.C. 319. Quinethazone 320. Quinidine Bisulphate 321. Rasberry Syrup, B.P.C. 322. Rauwolfia Alkaloids 323. Rauwolfia Serpentina, B.P.C. 324. Red Back Spider Antivenene 325. Rolitetracyclinc 326. Rosemary Oil, B.P.C. 327. Salbutamol 328. Salicylamide 329. Secbutobarbitone Sodium 330. Senega, Concentrated Infusion, B.P.C. 1968 331. Senna Fruit Extract (Standardised) 332. Siberian Fir Oil, B.P.C. 1949 333. Silver Protein, B.P.C. 334. Silver Protein Mild, B.P.C. 335. Similac Isomil 336. Snake Bite Antivenene—Polyvalent 337. Sobee 338. Sodium Lactate 339. Sodium Lactate Compound Injection, B.P. with Dextrose 340. Sodium Nitroprusside 341. Sodium Potassium Tartrate. B.P.C. 342. Sodium Tauroglycocholate, B.P.C. 1954 | 343. Sorbide Nitrate 344. Sorbitol 345. Soyalac 346. Spectinomycin Dihydrochloride Pentahydrate 347. Squill Tincture, B.P.C. 348. Stanolone 349. Stanozolol 350. Stearic Acid, B.P.C. 351. Stilboestrol Diphosphate 352. Stone Fish Antivenene 353. Streptokinase 354. Strychnine, B.P.C. 1959 355. Sulphaethidole 356. Sulphamethoxazole 357. Sulphaphenazole, B.P.C. 358. Sulphasalazine 359. Sulphasymazine 360. Sulphurated Potash, B.P.C. 361. Sulphur Sublimed, B.P.C. 362. Surgical Cement 363. Surgical Cement Solvent 364. Tacrine 365. Taipan Antivenene 366. Tartrazine, B.P.C. 1954 367. ‘TERIC’ N8 368. Testosterone Decanoate 369. Testosterone Enanthate 370. Testosterone Isocaproate 371. Tetracosactrin 372. Tetracycline, B.P.C. 373. Thiabendazole 374. Thiethylperazine Malate 375. Thiethylperazine Maleate 376. Thioridazine 377. Thonzonium Bromide 378. Thonzylamine Hydrochloride 379. Thyrotrophin 380. Tiemonium Iodide 381. Tiger Snake Antivenene 382. Titanium Dioxide, B.P.C. 383. Tolazamide 384. Tragacanth, Indian (Gum Karaya) 385. Tragacanth Mucilage 386. Tridihexethyl Chloride 387. Triethanolamine, B.P.C. 388. Triglyde 389. Trimeprazine Tartrate. B.P.C. 390. Trimethoprim 391. Trimipramine Maleate 392. Trolnitrate Phosphate 393. Typhoid Vaccine 394. Vanillin 395. Vasopressin Tannate 396. Vinblastine Sulphate 397. Vincristine Sulphate 398. Vinyl Acetate 399. Vinyl Pyrrolidone 400. Vitamin A 401. Vitamin D 402. Zinc Gelatin, B.P.C. |
______________
FOURTH SCHEDULE Regulation 12.
Additives
1. Acetone, B.P.C. 2. Alcohol (95%), B.P. 3. Arachis Oil, B.P. 4. Amethocaine Hydrochloride, B.P. 5. Camphor, B.P. 6. Carmine Solution, A.P.F. 7. Castor Oil, B.P. 8. Citronella Oil, B.P.C. 9. Chlorhexidine Gluconate Solution, B.P. 10. Chloroform, B.P. 11. Concentrated Anise Water, B.P.C. 12. Concentrated Cinnamon Water, B.P.C. 13. Concentrated Peppermint Water, B.P. 14. Dextrose Monohydrate, B.P. | 15. Dilute Alcohols, B.P. 16. Ether Anaesthetic, B.P. 17. Eucalyptol, B.P.C. 18. Eucalyptus Oil, B.P. 19. Honey—Purified, B.P.C. 20. Maize Oil, B.P. 21. Olive Oil, B.P. 22. Peppermint Oil, B.P. 23. Sodium Thiosulphate, B.P.C. 24. Solution of Burnt Sugar, B.P.C. 1959 25. Spirit, Methylated, Industrial, B.P. 26. Syrup of Pholcodine Citrate, B.P.C. 1959 27. Turpentine Oil, B.P. 28. Xylene, B.P.C. 1949 |
______________
FIFTH SCHEDULE Regulation 14.
Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
1 | Acetylcysteine............... | Cystic Fibrosis (mucoviscidosis) |
2 | (1) Aspirin with Paracetamol and Caffeine Tablets | Any disease or condition in a pensioner |
| (2) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets |
|
3 | Acrylic Resin................ | Ileostomy or colostomy conditions |
4 | Albumaid XP................ | With the written authority of the Director-General, phenylketonuria |
5 | Aldosterone................. | With the written authority of the Director-General, treatment of an acute crisis in adrenal cortical hypofunction (including Addison’s disease, bilateral adrenalectomy and salt-losing congenital adrenal hyperplasia) |
6 | Alprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
7 | Alprenolol Hydrochloride Tablets | With the written authority of the Director-General— |
| Idiopathic hypertrophic subaortic stenosis | |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
8 | Amantadine Hydrochloride….….….…. | With the written authority of the Director-General, the treatment of Parkinson’s disease caused otherwise than by treatment with a drug |
9 | Aminocaproic Acid….….….….….…... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
10 | Aminogran................. | With the written authority of the Director-General, phenylketonuria |
11 | Aminosalicylic Acid........... | Tuberculosis |
12 | Amphotericin B Injection........ | Systemic mycoses |
13 | (1) Ampicillin Capsules, B.P. | Infections by susceptible organisms where these cannot be safely and effectively treated with sulphonamides, or any of the following administered orally—benzyl penicillin, phenoxymethyl—penicillin or phenethicillin |
| (2) Ampicillin Injections, Tablets and Syrups | |
|
| Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to ampicillin |
|
| Urinary tract infections where a patient who is sensitive to sulphonamides |
14 | Ascorbic Acid Tablets, B.P. | Any disease or condition in a pensioner |
15 | Azathioprine................ | With the written authority of the Director-General, azathioprine therapy for a person who has been discharged from an approved hospital and received that therapy while a patient in the hospital |
16 | Benzathine Penicillin, B.P....... | Prophylaxis of recurrent streptococcal infections (including rheumatic fever) |
17 | Benzoin Compound Tincture, B.P.C. aerosol spray | Ileostomy or colostomy conditions |
18 | Benzylpenicillin Injection, 5,000,000 units | Bacterial endocarditis or septicaemia |
19 | Benzylpenicillin Injection, 10,000,000 units | Bacterial endocarditis or septicaemia |
| Gastrointestinal surgery | |
20 | (1) Benzylpenicillin with Streptomycin Sulphate | Endocarditis due to streptococcus faecalis or streptococcus viridans |
| (2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate |
|
21 | Betahistine Hydrochloride....... | Meniere’s syndrome |
22 | Betamethasone Acetate and | Intra-articular use |
| Betamethasone Injection | With the written authority of the Director-General, preoperative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy |
23 | Busulphan Tablets, B.P. | Treatment in malignant neoplasia |
24 | (1) Calciferol Tablets, Strong, B.P. | Any disease or condition in a pensioner |
|
| With the written authority of the Director-General— |
| (2) Calciferol, B.P. | Hypoparathyroidism |
|
| Osteomalacia following gastrectomy |
|
| Vitamin D-resistant rickets |
25 | Calcium Aminosalicylate........ | Tuberculosis |
26 | Capreomycin Sulphate.......... | Tuberculosis |
27 | Carbamazepine.............. | Epilepsy |
|
| Trigeminal neuralgia |
28 | Carbenicillin Sodium.......... | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent |
29 | Carbenoxolone Sodium......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, gastric ulcer where a radiological examination or other appropriate tests have confirmed the presence of a gastric ulcer |
30 | Cephalexin Monohydrate........ | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
31 | Cephaloridine............... | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent |
32 | Cephalothin Sodium........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent |
33 | Ceratonia.................. | Oesophageal reflux in infants |
34 | Charcoal Tablets............. | Ileostomy or colostomy conditions |
35 | Chlorambucil Tablets, B.P....... | Treatment in malignant neoplasia |
36 | Chloramine Deodorant Tablets and powder | Ileostomy or colostomy conditions |
37 | (1) Chloramphenicol Capsules, B.P. | Bacterial meningitis |
| Intraocular infections | |
| (2) Chloramphenicol Injections | Rickettsioses |
| Typhoid | |
| (3) Chloramphenicol Oral Suspension | The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient |
38 | Chlorotrianisene Tablets........ | Carcinoma of the prostate |
39 | (1) Chlorpromazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Chlorpromazine Injection, B.P. | Major psychoses including— |
| Major organic psychoses | |
| (3) Chlorpromazine Tablets, B.P. | Manic psychoses |
| Paranoid states | |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
40 | Cholestyramine.............. | With the written authority of the Director-General— |
|
| Bile salt malabsorption associated with ileal resection or proven ileal disease |
|
| Pruritis associated with partial biliary obstruction not responding to other therapy |
|
| Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type 11) not responding to other therapy |
|
| A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type 11) in patients who respond to treatment with cholestyramine but do not respond to other therapy |
41 | Clofibrate.................. | With the written authority of the Director-General— |
|
| Diabetic retinopathy (exudative) |
|
| Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy |
|
| A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report |
42 | (1) Cloxacillin Sodium, B.P...... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Cloxacillin Capsules, B.P. | |
|
| With the written authority of the Director-General, serious infections where bacteriological evidence confirms the presence of penicillinase-producing staphylococci |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
43 | (1) Codeine Phosphate with Aspirin Soluble Tablets | Any disease or condition in a pensioner |
| (2) Codeine Phosphate with Aspirin Tablets |
|
| (3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets |
|
| (4) Codeine Phosphate with Aspirin and Paracetamol Tablets |
|
| (5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets |
|
44 | Colistin Sulphomethate Sodium, B.P., for injection | Pyocyaneus infection, other gram-negative infections where no other drug is effective |
45 | Cyanocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
46 | Cycloserine Capsules, B.P........ | Tuberculosis |
47 | Cymogran.................. | With the written authority of the Director-General, phenylketonuria |
48 | (1) Cyproheptadine Hydrochloride, B.P. | Allergic rhinitis |
| Allergic dermatoses | |
| (2) Cyproheptadine Tablets, B.P. | Migraine |
49 | Cytosine Arabinoside Hydrochloride | Any disease or condition in a patient receiving treatment in or at an approved hospital |
50 | Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and ‘TERIC’ N8) | Ileostomy or colostomy conditions |
51 | (1) Deoxycortone Acetate Injection, B.P. | Adrenal cortical hypofunction (including Addison’s disease, bilateral adrenalectomy and salt-losing congenital adrenal hyperplasia) |
| (2) Deoxycortone Acetate Implants, B.P. | |
| (3) Deoxycortone Acetate, B.P. |
|
52 | Desferrioxamine Mesylate....... | Acute iron poisoning |
|
| Hepatolenticular degeneration |
53 | (1) Dextromoramide Tablets, B.P. | Treatment in malignant neoplasia |
| (2) Dextromoramide Tartrate, B.P. |
|
54 | Dextrose Polymer............. | With the written authority of the Director-General, phenylketonuria |
55 | (1) Diazepam, B.P., Syrup....... | Any disease or condition in a pensioner |
| (2) Diazepam Tablets, B.P........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| The treatment of a mental disorder in a patient discharged from an approved hospital at which he received treatment for a mental disorder |
|
| Epilepsy |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Motor neurone lesion |
|
| Multiple sclerosis |
|
| Radiation sickness |
|
| Stiff-man syndrome |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
56 | Diazoxide.................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
57 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
58 | Dienoestrol Cream............ | Any disease or condition in a pensioner |
59 | (1) Dihydroergotoxine Mesylate Tablets | For the treatment of patients who have suffered an attack of paralytic poliomyelitis |
| (2) Dihydroergotoxine Mesylate Injection |
|
60 | Dihydrotachysterol............ | Hypoparathyroidism |
61 | Dimethicone Aerosol Spray | Ileostomy or colostomy conditions |
62 | Dimethicone Creams.......... | Use with surgical appliances |
63 | (1) Dioctyl Sodium Sulphosuccinate | Any disease or condition in a pensioner |
| (2) Dioctyl Sodium Sulphosuccinate with Danthron |
|
64 | Disodium Cromoglycate........ | With the written authority of the Director-General, the treatment of chronic intractable asthma |
65 | Droperidol................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
66 | Epicillin................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
67 | Ethacrynic Acid.............. | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
68 | Ethinyloestradiol Tablets, B.P. | Any disease or condition in a pensioner |
|
| Carcinoma of the breast post-menopausal |
|
| Carcinoma of the prostate |
|
| Hereditary telangiectasis |
|
| Premature menopause that is surgically induced |
|
| Turner’s syndrome |
69 | Ethionamide................ | Tuberculosis |
70 | Ethisterone Tablets, B.P......... | Turner’s syndrome |
71 | Ethyloestrenol............... | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Osteomalacia following gastrectomy |
72 | Fludrocortisone Tablets, B.P. | Adrenal cortical hypoplasia including Addison’s disease |
|
| Total adrenalectomy |
73 | Fluorouracil Sodium........... | Treatment in malignant neoplasia |
74 | Fluoxymesterone Tablets, B.P. | Eunuchism |
|
| Eunuchoidism Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Proven aplastic anaemias |
75 | (1) Fluphenazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Fluphenazine Tablets, B.P. | Major psychoses including— |
| (3) Fluphenazine Enanthate | Major organic psychoses |
| (4) Fluphenazine Decanoate | Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
76 | (1) Folic Acid, B.P............ | Cystic Fibrosis |
| (2) Folic Acid Tablets, B.P. 5 mg | Proven folic acid deficiency |
Sprue or the sprue-like syndrome | ||
77 | Folic Acid Tablets, B.P. 0.5 mg. | Cystic Fibrosis |
|
| Pregnancy |
78 | Framycetin Sulphate Injection | Sub-conjunctival injection in the treatment of serious ocular inflammation |
79 | Framycetin Sulphate Tablets | Bowel sterilization preparatory to major surgery |
80 | Frusemide Tablets, B.P.......... | Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome |
|
| Fluid retention associated with other conditions and not responding to thiazides |
81 | Galactomin Formula No. 17 | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years |
82 | Galactomin Formula No. 19 | With the written authority of the Director-General, glucose-galactose malabsorption |
83 | Gentamicin Sulphate........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
84 | Glucose Indicator—Blood....... | With the written authority of the Director-General, diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing |
85 | Goat’s Milk, Dehydrated........ | With the written authority of the Director-General, cow’s milk allergy in children under the age of four years |
86 | Goat’s Milk, Whole (Sterilized) | With the written authority of the Director-General, cow’s milk allergy in children under the age of four years |
87 | (1) Griseofulvin, B.P........... | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light |
| (2) Griseofulvin Tablets, B.P.
| |
88 | Halibut Liver Oil Capsules....... | Any disease or condition in a pensioner |
89 | Haloperidol................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
|
| Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
90 | Hydrocortisone Acetate Injection, B.P. | Intra-articular use |
91 | Hydrocortisone Sodium Succinate Injection, 100 mg. | Acute medical or surgical crisis |
| Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy | |
92 | Hydrocortisone Sodium Succinate Injection, 250 mg. and 500 mg. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
93 | Hydroxocobalamin Injection, B.P. | Pernicious anaemia and other proven Vitamin B-12 deficiencies |
|
| Post gastrectomy treatment |
|
| Sub-acute combined degeneration of the cord |
|
| Neuroblastoma |
94 | Hydroxyprogesterone Caproate | Carcinoma of the endometrium |
Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
95 | Hydroxyurea | Any disease or condition in a patient receiving treatment in or at an approved hospital |
96 | Idoxuridine................. | Infections caused by Herpes Simplex Virus |
97 | Influenza Vaccine............ | For prophylaxis of pensioners only |
98 | Insect Allergen Extract—Honey Bee | With the written authority of the Director-General, severe constitutional reaction to bee stings |
99 | Insect Allergen Extract—Jumper Ant | With the written authority of the Director-General, severe constitutional reaction to jumper ant stings |
100 | Insect Allergen Extract—Paper Wasp | With the written authority of the Director-General, severe constitutional reaction to wasp stings |
101 | Isoniazid Tablets, B.P........... | Tuberculosis |
102 | Isoprenaline Hydrochloride Tablets, 30 mg. | Stokes-Adams Syndrome |
103 | Kanamycin Sulphate Injections | With the written authority of the Director-General— |
| Infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic | |
|
| Septicaemia, including suspected septicaemia |
104 | Lactulose.................. | Hepatic coma or pre-coma (chronic portosystemic encephalopathy) |
105 | Leucovorin................. | Antidote to folic acid antagonists |
106 | Levodopa.................. | With the written authority of the Director-General, treatment of Parkinson’s Disease |
107 | Lignocaine Injection, B.P........ | Cardiac arrhythmias |
108 | Lincomycin Hydrochloride...... | Gram positive coccal infections where these cannot be safely and effectively treated with a penicillin |
|
| Osteomyelitis |
109 | Liothyronine Tablets, B.P........ | Myxoedema |
110 | Lithium Carbonate Tablets, B.P.... | With the written authority of the Director-General, manic depression |
111 | Locasol................... | With the written authority of the Director-General, Hypercalcaemia in children under the age of two years |
112 | Lofenalac.................. | With the written authority of the Director-General, phenylketonuria |
113 | Lypressin Nasal Spray.......... | Diabetes insipidus |
114 | Maphenide Acetate............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
115 | Medroxyprogesterone Acetate Tablets, 2.5 mg. | Carcinoma of the endometrium |
116 | Medroxyprogesterone Acetate Tablets, 10 mg. | Carcinoma of the endometrium |
| Precocious puberty | |
117 | Medroxyprogesterone Acetate Tablets, 100 mg. | Carcinoma of the breast |
| Carcinoma of the endometrium | |
|
| Hypernephroma |
118 | Medroxyprogesterone Acetate Injections | Carcinoma of the endometrium |
| Hypernephroma | |
|
| Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy |
119 | Melphalan................. | Treatment in malignant neoplasia |
120 | Mercaptopurine Tablets, B.P. | Allergic granulomatous angiitis |
|
| Lupus erythematosus |
|
| Nephrotic syndrome |
|
| Periarteritis (Nodosa) |
|
| Treatment in malignant neoplasia |
121 | (1) Methandienone Tablets, B.P. | With the written authority of the Director-General— |
| (2) Methenolone Acetate | Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
122 | Methicillin Sodium, B.P., for Injection | Proven or suspected staphylococcal septicaemia |
123 | (1) Methotrexate Tablets........ | Treatment in malignant neoplasia |
| (2) Methotrexate Injections...... | Pemphigus vulgaris |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
124 | Methylprednisolone Acetate Retention Enema | With the written authority of the Director-General— |
| Colitis, ulcerative, proven by sigmoidoscopy or radiological report | |
|
| Proctitis, proven by sigmoidoscopy |
125 | Methylprednisolone Acetate Injection | Intra-articular use |
126 | (1) Methyltestosterone Tablets, B.P. | Carcinoma of the breast |
| Eunuchism | |
|
| Eunuchoidism |
| (2) Methyltestosterone, B.P. | Klinefelter’s syndrome (seminiferous tubulo dysgenesis) |
127 | Methysergide Maleateot......... | Treatment of severe recalcitrant migraine where other treatment has failed |
128 | Metyrapone................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
129 | Minafen................... | With the written authority of the Director-General phenylketonuria |
130 | Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain |
131 | Mustine Hydrochloride Injection | Treatment in malignant neoplasia |
132 | Nalidixic Acid............... | Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nalidixic acid or where the patient is sensitive to sulphonamides |
133 | Nandrolone Decanoate......... | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Severe osteoporosis due to proven pancreatitis |
134 | Nandrolone Hexoxyphenyl Propionate | Carcinoma of the breast |
| With the written authority of the Director-General— | |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
|
| Intermittent use for corticosteroid-induced osteoporosis |
135 | Nandrolone Phenylpropionate Injection, B.P. | Carcinoma of the breast |
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |
136 | Neomycin Sulphate Powder | With the written authority of the Director-General, use by inhalation in Cystic Fibrosis (mucoviscidosis) |
|
| |
137 | Neomycin Tablets, B.P.......... | Bowel sterilization preparatory to major surgery |
|
| Encephalopathy, hepatic |
|
| Enteropathogenic E. coli infections in infants |
138 | Nicotinic Acid Tablets, B.P. | Any disease or condition in a pensioner |
139 | (1) Nitrofurantoin Tablets, B.P. | Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides |
| ||
| (2) Nitrofurantoin Oral Suspension | |
| ||
140 | Nitromin................... | Treatment of malignant neoplasia |
141 | Norethisterone Acetate, B.P. | Carcinoma of the breast |
142 | Norethisterone Tablets, B.P. | Endometriosis |
|
| Metropathia haemorrhagica |
|
| Precocious puberty |
143 | Nutramigen................. | With the written authority of the Director-General— |
|
| Cow’s milk allergy in children under the age of four years |
|
| Cystic Fibrosis (mucoviscidosis) |
|
| Galactosaemia |
|
| Lactose intolerance |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
144 | Oxprenolol Hydrochloride Tablets | With the written authority of the Director-General— |
| Idiopathic hypertrophic subaortic stenosis | |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
145 | Oxprenolol Hydrochloride Injection | Idiopathic hypertrophic subaortic stenosis |
| Right ventricular outflow tract obstruction | |
|
| Dissecting aneurysm, aortic |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
146 | Oxycodone Pectinate........... | Treatment in malignant neoplasia |
147 | Oxymetholone............... | With the written authority of the Director-General— |
|
| Proven aplastic anaemias |
|
| Myelosclerosis |
148 | (1) Pancreatin, B.P............. | Cystic Fibrosis (mucoviscidosis) |
| (2) Pancreatin Enzyme 4X U.S.N.F. XII | Following pancreatico-duodenectomy |
| Pancreatic steatorrhoea | |
| (3) Pancrelipase |
|
149 | Paracetamol with Codeine Phosphate and Pentobarbitone Sodium | Any disease or condition in a pensioner |
150 | (1) Paraffin Liquid Emulsion | Any disease or condition in a pensioner |
| (2) Paraffin Liquid Emulsion with Phenolphthalein |
|
151 | Penicillamine................ | With the written authority of the Director-General— |
|
| Acute heavy metal intoxication |
|
| Cystinosis |
|
| Cystinuria with calculus formation |
|
| Haemoglobinuria, paroxysmal cold |
|
| Wilson’s disease (hepatolenticular degeneration) |
152 | (1) Pericyazine Mesylate | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Pericyazine | Major psychoses, including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
153 | Phytomenadione Injection, 10 mg. per ml. | Antidote to anticoagulants |
| Haemorrhagic diathesis associated with malabsorption | |
154 | Phytomenadione Injection, B.P., 1 mg. in 1 ml. | Antidote to anticoagulants |
| Haemorrhagic diathesis associated with malabsorption | |
|
| Suspected cerebral trauma of the new born |
|
| Haemorrhagic disease of the new born |
155 | Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus |
156 | Pizotifen Malate.............. | The treatment of severe migraine in a patient whose attacks of migraine do not respond to treatment by other therapeutic agents |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
157 | (1) PK AID I................ | With the written authority of the Director-General, phenylketonuria |
| (2) PK AID II................ | |
158 | Plasma Subsititute (Polypeptide) | Any disease or condition in a patient receiving treatment in or at an approved hospital |
159 | Polyisobutylene.............. | Ileostomy or colostomy conditions |
160 | Polymyxin B. Sulphate Powder | With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis) |
161 | Polyoestradiol Phosphate........ | Carcinoma of the breast |
|
| Carcinoma of the prostate |
162 | Practolol Injection............. | Dissecting aneurism, aortic |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
163 | Practolol Tablets.............. | With the written authority of the Director-General— |
|
| Dissecting aneurysm, aortic |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
164 | Prednisolone Sodium Phosphate Retention Enema and Suppository | With the written authority of the Director-General— |
| Ulcerative colitis proven by sigmoidoscopy or radiological report | |
|
| Proctitis proven by sigmoidoscopy |
165 | (1) Prednisolone Acetate Injection | Intra-articular use |
| (2) Prednisolone Butyl Acetate Injection |
|
166 | Prednisolone Acetate with Phenylephrine Hydrochloride, B.P. | Corneal grafts |
| Uveitis | |
167 | Prednisolone Sodium Phosphate Injection, B.P. | Acute medical or surgical crisis |
| Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy | |
168 | Prednisolone Sodium Succinate Injection | Acute medical or surgical crisis |
| Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy | |
169 | Prindolol Injection | Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
170 | Prindolol Tablets........... | With the written authority of the Director-General— |
|
| Dissecting aneurysm (aortic) |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Initial treatment of severe hypertensive disease where the diastolic pressure is constantly above 130 mm. and the disease has not responded to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| A second or subsequent course of treatment for severe hypertensive disease in patients whose condition responds to prindolol |
171 | Procarbazine Hydrochloride | Treatment in malignant neoplasia |
172 | (1) Prochlorperazine | Meniere’s Syndrome |
| (2) Prochlorperazine Tablets, B.P. |
|
173
| Progesterone..............
| Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy |
174 | Promethazine Theoclate Tablets, B.P. | Vomiting in pregnancy |
175 | Propranolol Injection, B.P..... | Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
176 | Propranolol Tablets, B.P....... | With the written authority of the Director-General— |
|
| Idiopathic hypertrophic subaortic stenosis |
|
| Right ventricular outflow tract obstruction |
|
| Dissecting aneurysm (aortic) |
|
| The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| Serious arrhythmias |
|
| Thyrotoxicosis |
|
| Initial treatment of severe hypertensive disease where the diastolic pressure is constantly above 130 mm. and the disease has not responded to other therapeutic agents except other beta-adrenergic receptor blocking agents |
|
| A second or subsequent course of treatment for severe hypertensive disease in patients whose condition responds to propranolol |
177 | Proscillaridin.............. | Patients intolerant of oral forms of prepared digitalis, digoxin and lanatoside C |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
178 | Prosobee................... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
179 | Pyrazinatnide................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
180 | Pyridoxine Hydrochloride Tablets | Homocystinuria |
| Radiation sickness | |
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy |
|
| Sideroblastic (refractory) anaemia |
|
| Proven pyridoxine responsive anaemia |
|
| With the written authority of the Director-General, primary hyperoxaluria |
181 | Riboflavine Tablets............ | Any disease or condition in a pensioner |
182 | Senna Fruit Extract (standardised) | Any disease or condition in a pensioner |
183 | Similac Isomil............... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
184 | Sobee..................... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
185 | (1) Sodium Aminosalicylate Tablets, B.P. | Tuberculosis |
| (2) Sodium Aminosalicylate Injection |
|
| (3) Sodium Aminosalicylate Cachets |
|
| (4) Sodium Aminosalicylate Granules |
|
| (5) Sodium Aminosalicylate with Isoniazid, B.P. |
|
186 | (1) Sodium Fusidate........... | With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence |
| (2) Diethanolamine Fusidate | |
187 | Soyalac.................... | With the written authority of the Director-General— |
|
| Galactosaemia |
|
| Homocystinuria |
|
| Lactose intolerance |
|
| Milk allergy in children under the age of four years |
188 | Spectinomycin Dihydrochloride Pentahydrate | Gonorrhoea
|
189 | Spironolactone Tablets, B.P. | With the written authority of the Director-General— |
|
| To supplement other diuretics when these have proved inadequate |
|
| Myasthenia gravis |
|
| Primary hyperaldosteronism |
190 | Stanolone.................. | Carcinoma of the breast |
|
| With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
191 | Stanozolol................. | With the written authority of the Director-General— |
|
| Intermittent use for corticosteroid-induced osteoporosis |
|
| Intermittent use for patients on long-term treatment with corticosteroids |
192 | Stilboestrol Diphosphate........ | Carcinoma of the prostate |
193 | Streptokinase................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
194 | Sulphasalazine............... | Ulcerative colitis |
195 | (1) Surgical Cement........... | Ileostomy or colostomy conditions |
| (2) Surgical Cement Solvent...... | For use with surgical appliances |
196 | (1) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate | Eunuchoidism |
| Eunuchism | |
| Klinefelter’s syndrome (seminiferous tubule dysgenesis) | |
| (2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate | Carcinoma of the breast |
| (3) Testosterone Implants, B.P. |
|
| (4) Testosterone Enanthate |
|
| (5) Testosterone Propionate Injection, B.P. |
|
197 | Tetanus Antitoxin, B.P. (Bovine) | Patients who have previously received an injection of equine serum |
198 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
199 | Thiethylperazine Maleate Tablets and Suppositories | Radiation sickness |
| Nausea resulting from cytotoxic therapy | |
200 | (1) Thioridazine.............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Thioridazine Tablets, B.P. | |
|
| Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Severe conduct disorders of children |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
201 | Thyrotrophin................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
202 | Tragacanth, Indian (Gum Karaya) | Ileostomy or colostomy conditions |
203 | Triamcinolone Acetonide Injection | With the written authority of the Director-General, treatment of keloids |
204
| (1) Trifluoperazine Hydrochloride, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| (2) Trifluoperazine Tablets, B.P. | Major psychoses including— |
|
| Major organic psychoses |
|
| Manic psychoses |
|
| Paranoid states |
|
| Schizophrenia |
|
| Hereditary chorea (Huntington’s) |
|
| Malignant neoplasia (late stage) |
|
| Radiation sickness |
205 | Triglyde................... | With the written authority of the Director-General, proven malabsorption |
Fifth Schedule—continued
First Column | Second Column | Third Column |
Item No. | Pharmaceutical Benefit | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
206 | Trimethoprim with Sulphamethoxazole | Infections by susceptible organisms where these cannot be safely and effectively treated with other sulphonamides, oral forms of benzyl penicillin, phenoxymethylpenicillin or phenethicillin |
|
| Urinary tract infections where other sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to trimethoprim with sulphamethoxazole |
|
| Ocular surgery |
207 | (1) Vinblastine Sulphate......... | Treatment in malignant neoplasia |
| (2) Vincristine Sulphate |
|
208 | Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray | Ileostomy or colostomy conditions |
209 | (1) Viomycin Sulphate......... | Tuberculosis |
| (2) Viomycin Sulphate Injection, B.P. |
|
210 | Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules | Any disease or condition in a pensioner |
Printed by Anthority by the Government Printer of the Commonwealth of Australia